Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jindun Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the development and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1992 and headquartered in Shaoxing, the company has built a robust portfolio focused on cardiovascular health, metabolic disorders, and anti-infective therapies. Jindun Pharma is particularly recognized for its production of statins and antihypertensive medications, which are distributed both domestically and to international markets including Europe and North America. The company operates state-of-the-art facilities that comply with international Good Manufacturing Practice (GMP) standards. In addition to its own product line, Jindun Pharma provides contract manufacturing and development services to global pharmaceutical partners. Their commitment to quality and research has made them a significant player in the global generic drug supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jindun Pharma.